The beneficial effect of metformin on <i>β</i>‐cell function in non‐obese Chinese subjects with newly diagnosed type 2 diabetes

Abstract

Metformin improved β-cell function in non-obese subjects with newly diagnosed T2DM, which was partly independent of the change in insulin sensitivity in these subjects. This study provides evidence-based data to support metformin use in non-obese patients with T2DM as the first-line agent, which can improve both insulin sensitivity and β-cell function.